New findings from the DiRECT trial reveal that weight loss can lead to type 2 diabetes remission. Learn about the benefits of a low-calorie diet and support in diabetes...

Sparling speaks out about the motivation behind her heartfelt, yet humorous collection of essays. She discusses growing up with diabetes, 'mentalbetes,' the power of...

Maximize fun in the sun this summer with our skincare guide for people with diabetes. Here we share tips for how to protect your skin and stay healthy during the hottest...

FDA warns people to avoid using some forms of compounded substitutes of semaglutides that lack the safety and efficacy of popular weight loss drugs Wegovy, Ozempic, and...

Reduce heart failure risk with FDA-approved Inpefa (sotagliflozin). Inhibiting SGLT-2 and SGLT-1, it outshines other medications. Learn more about its effectiveness and...

In case you missed them, here are our top stories from May 2023. This month’s best stories cover a wide variety of topics like upcoming therapies, new research findings...

Oculis' OCS-01 eye drops show promising results in phase 3 trials for diabetic macular edema treatment. Uncover a potential revolution in non-invasive eye care solutions.

Explore key insights from the second annual Diabetes + Mental Health Virtual Conference. Learn about the intersection of these two critical health areas from experts,...

This clinical trial is currently recruiting – participants will be enrolled in one of two stress-intervention courses to measures changes in A1C, diabetes distress, and...

Explore how US Senator Jeanne Shaheen champions diabetes care at diaTribe's forum. Discover her insights on advancing time in range, lowering insulin costs, and...

Early findings from a phase 3 clinical trial demonstrated that participants treated with 50 mg oral semaglutide achieved a remarkable weight loss of 17.4%. This research...

Non-invasive glucose monitoring technology has been a dream of people with diabetes for years. Get the latest update on the research and development of these devices.

The National Institute of Clinical Excellence recently announced it was the first to expand access to automated glucose monitors for children with type 2 diabetes. The...

Farxiga (dapagliflozin), a SGLT-2 inhibitor, has officially been approved by the FDA to treat all types of heart failure, a common diabetes complication.

Participate in Omada Health's 6-month online study for type 2 diabetes management. Earn up to $250, experience their program, and contribute to diabetes research – all...

What is the gut microbiome? There are five well-known organs that humans need to survive – the heart, lungs, brain, kidneys, and liver. However, some studies indicate...

Explore the challenges, insights, and triumphs of growing old with diabetes as long-term patients share their experiences and valuable advice.

With Mother’s Day 2023 coming up this Sunday, May 14, there’s no time to waste to find a special present for your special person with diabetes.

Early-stage study results show that a new one-hour intestinal procedure called ReCET may be able to help people with type 2 diabetes improve their blood sugars enough to...

Researchers released early clinical trial results on an innovative cell treatment for people with type 2 diabetes. After one year, 93% of those who received the...